PetCaseFinder

Peer-reviewed veterinary case report

A Study of Cross-Protection betweenImmunovariants.

Journal:
Pathogens (Basel, Switzerland)
Year:
2024
Authors:
Jenkins, Mark C et al.
Affiliation:
Animal Parasitic Diseases Laboratory · United States

Abstract

For reasons unknown,is unique amongspecies infecting chickens in the immunovariability it displays among isolates from different geographical areas.oocysts (named EmaxAPU3) were isolated late in grow-out (6 weeks) from litter in a commercial broiler operation that was usingvaccination as the coccidiosis control program. Cross-protection studies (n = 4) were conducted in immunologically naïve chickens between EmaxAPU3 and twolab strains (EmaxAPU1, EmaxAPU2) by immunizing with onestrain and challenging with either the homologous or heterologous. As measured by oocyst output, immunization with EmaxAPU1 protected against homologous challenge (EmaxAPU1) and against heterologous challenge with EmaxAPU3, but not against EmaxAPU2. Similarly, immunization with EmaxAPU3 protected against homologous challenge (EmaxAPU3) and against heterologous challenge with EmaxAPU1, but not against EmaxAPU2. Immunization of chickens with EmaxAPU2 elicited a protective response against homologous challenge (EmaxAPU2), but not against EmaxAPU1 nor EmaxAPU3. The most plausible explanation for the appearance of this immunovariant late in grow-out is thatAPU3 escaped immunity directed toantigenic types in the commercial vaccine.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication: https://pubmed.ncbi.nlm.nih.gov/38251373/